Home/Filings/4/0001193125-26-004580
4//SEC Filing

WILSON TROY EDWARD 4

Accession 0001193125-26-004580

CIK 0001422143other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:31 PM ET

Size

5.3 KB

Accession

0001193125-26-004580

Insider Transaction Report

Form 4
Period: 2026-01-02
WILSON TROY EDWARD
DirectorPresident and CEO
Transactions
  • Award

    Option to purchase common stock

    2026-01-02+1,120,0001,120,000 total
    Exercise: $10.34Exp: 2036-01-01Common Stock (1,120,000 underlying)
Footnotes (1)
  • [F1]This option vests in 48 equal monthly installments commencing on the grant date.

Documents

1 file

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeother

Related Parties

1
  • filerCIK 0001589597

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:31 PM ET
Size
5.3 KB